Dr. Lehman on Breast Imaging Across Cancer Centers

Constance D. Lehman, MD, PhD
Published: Monday, Jul 22, 2013

Constance D. Lehman, MD, PhD, Vice Chair, Radiology Department, University of Washington School of Medicine, Medical Director, Imaging, Seattle Cancer Care Alliance, discusses breast imaging across various cancer centers.

Advanced imaging technology, whether tomosynthesis, breast MRI, or PET exams, is not the same. For example, Lehman says, in breast MRIs, there are several ways to obtain and interpret a breast MR exam.

Lehman says that she is pleased that the American College of Radioology is supporting a rigorous accreditation program. This program requires sites to submit images and provide information about radiologists to demonstrate high-level performance. This type of accreditation process, which was piloted by the Seattle Cancer Care Alliance, provides crucial information to patients and the community.

Constance D. Lehman, MD, PhD, Vice Chair, Radiology Department, University of Washington School of Medicine, Medical Director, Imaging, Seattle Cancer Care Alliance, discusses breast imaging across various cancer centers.

Advanced imaging technology, whether tomosynthesis, breast MRI, or PET exams, is not the same. For example, Lehman says, in breast MRIs, there are several ways to obtain and interpret a breast MR exam.

Lehman says that she is pleased that the American College of Radioology is supporting a rigorous accreditation program. This program requires sites to submit images and provide information about radiologists to demonstrate high-level performance. This type of accreditation process, which was piloted by the Seattle Cancer Care Alliance, provides crucial information to patients and the community.




View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: CDK4/6 Inhibitors With the Experts: The Role of Emerging Agents for the Management of Metastatic Breast CancerMay 30, 20182.0
Medical Crossfire®: Clinical Updates on PARP Inhibition and its Evolving Use in the Treatment of CancersMay 30, 20181.5
Publication Bottom Border
Border Publication
x